Evidence map›Paper›PMID 32294890›Full record

ArticleMolecules (Basel, Switzerland)2020

Impact of Isoorientin on Metabolic Activity and Lipid Accumulation in Differentiated Adipocytes.

Khanyisani Ziqubu, Christo J F Muller, Phiwayinkosi V Dludla, Sinenhlanhla X H Mthembu, Nnini Obonye, Johan Louw, Abidemi P Kappo, Sonia Silvestri, Patrick Orlando, Luca Tiano and 1 more

Open access · goldFull text read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Pennogenin 3-International journal of molecular sciences · 2024
    Article
  12. In Silico Studies of Four Compounds ofMolecules (Basel, Switzerland) · 2023
    Article
  13. Wheat sprouts (Food science and biotechnology · 2023
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Khanyisani ZiqubuBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Christo J F MullerBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Phiwayinkosi V DludlaBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.ORCID 0000-0001-5965-3610
Sinenhlanhla X H MthembuBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Nnini ObonyeBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Johan LouwBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.
Abidemi P KappoDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.ORCID 0000-0003-2521-8957
Sonia SilvestriDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Patrick OrlandoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.
Luca TianoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.ORCID 0000-0002-7519-7106
Sithandiwe E Mazibuko-MbejeBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa.ORCID 0000-0002-0946-8027
South African Medical Research Council · ZAMarche Polytechnic University · ITUniversity of Zululand · ZA

Funding

National Reserarch Foundation (ZA) 80618 and 113674
6 · The paper itself

Abstract

The current study explored the effect of isoorientin on the metabolic activity and lipid accumulation in fully differentiated 3T3-L1 adipocytes. To achieve this, the 3T3-L1 pre-adipocytes were differentiated for eight days and treated with various concentrations of isoorientin (0.1-100 μM) for four hours. Subsequently, the metabolic activity, lipid accumulation, and mitochondrial respiration were assessed. Furthermore, to unravel the molecular mechanisms that might elucidate the bioactivity of isoorientin, protein expression of the genes involved in insulin signaling and energy expenditure, such as AKT and AMPK, were investigated. The results showed that isoorientin, at different doses, could block lipid storage and enhance glycerol release, with a concomitant improvement of the metabolic activity and mitochondrial function. Although the observed beneficial effects of isoorientin on these cultured 3T3-L1 adipocytes were not consistent at all concentrations, it was clear that doses between 1 and 10 μM were most effective compared to the untreated control. Moreover, the activity of isoorientin was comparable to tested positive controls of CL-316,2431, isoproterenol, insulin, and metformin. Mechanistically, protein expression of AKT and AMPK, was enhanced with isoorientin exposure, suggesting their partial role in modulating lipid metabolism and mitochondrial biogenesis. Indeed, our results showed that isoorientin has the ability to enhance mitochondrial respiration, as we observed an increase in the ATP and oxygen consumption rate. Therefore, we concluded that isoorientin has a potential to impact mitochondrial activity, lipid metabolism and energy expenditure using an in vitro experimental model of obesity.

Indexed as

3T3-L1 CellsAdenosine TriphosphateAdipocytesAMP-Activated Protein Kinase KinasesAnimalsDioxolesGlucoseInsulinIsoproterenolLipid MetabolismLuteolinMetforminMiceMitochondriaObesityProtein KinasesAdenosine TriphosphateAMP-Activated Protein Kinase KinasesDioxolesdisodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylateGlucosehomoorientinInsulinIsoproterenolLuteolinMetforminProtein KinasesProto-Oncogene Proteins c-akt3T3-L1 adipocytesisoorientinlipid accumulationmetabolic activityobesity

Identifiers

PMID32294890
PMCPMC7221924
OpenAlexW3015585067

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.